West Pharmaceutical Services Inc (NYSE:WST) Share Price

Company Profile

Business description
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Contact
530 Herman O. West Drive
ExtonPA19341-1147
USA
T: +1 610 594-2900
E: [email protected]
https://www.westpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
10,800

Recommended

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 27 January 2026

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.

Susan Dziubinski | 26 June 2025

Index	Last price	Change	% Change
All Ordinaries	9,003.00	6.60	0.07%
CAC 40	8,364.65	25.69	0.31%
DAX 40	25,114.25	47.16	0.19%
Dow JONES (US)	52,449.31	187.70	-0.36%
FTSE 100	10,498.29	1.00	0.01%
HKSE	24,213.72	38.60	0.16%
NASDAQ	25,829.42	452.19	-1.72%
Nikkei 225	67,242.73	1,315.00	-1.92%
NZX 50 Index	13,723.20	62.47	-0.45%
S&P 500	7,508.49	66.90	-0.88%
S&P/ASX 200	8,808.50	11.70	0.13%
SSE Composite Index	3,913.79	82.37	-2.06%